01—Abstract
Summary
Summary of the 8-K filed February 20, 2024. Cited figures are marked; the original filing is the authoritative source.
Jacobs Solutions Inc. ("Jacobs") disclosed under Item 7.01 (Regulation FD) that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for its previously announced Reverse Morris Trust transaction involving its Critical Mission Solutions and Cyber and Intelligence businesses and Amentum Parent Holdings LLC ("Amentum") expired at 11:59 p.m.
ET on February 16, 2024. The HSR expiration was a condition to closing, but completion remains subject to other conditions, including receipt of other regulatory approvals, a private letter ruling from the Internal Revenue Service, opinions from tax advisors, and effectiveness of a registration statement with the U.S. Securities and Exchange Commission. Jacobs expects the transaction to close in the second half of fiscal year 2024.
Jacobs also determined that it does not intend to retain more than 8%a of the issued and outstanding shares of the combined company's common stock, after accounting for certain post-closing adjustments to the merger consideration owed to the sole shareholder of Amentum, if any. Any additional shares above 8% will be distributed to Jacobs' shareholders at or as soon as reasonably practicable after consummation of the transaction.
The filing is informational in nature and does not report new financial results. Investors should weigh the remaining closing conditions and the timing guidance, as the transaction's completion and the share distribution depend on those items being satisfied.
02—Key points
Key Highlights
- HSR antitrust waiting period for the Reverse Morris Trust transaction with Amentum Parent Holdings LLC expired at 11:59 p.m. ET on February 16, 2024.
- HSR expiration satisfies one closing condition, but the transaction still requires other regulatory approvals, an IRS private letter ruling, tax advisor opinions, and an effective SEC registration statement.
- Jacobs expects the transaction to close in the second half of fiscal year 2024.
- The transaction involves Jacobs' Critical Mission Solutions and Cyber and Intelligence businesses.
- Jacobs does not intend to retain more than 8% of the combined company's common stock, after certain post-closing merger consideration adjustments, if any.
- Shares above the 8% retention level will be distributed to Jacobs' shareholders at or as soon as reasonably practicable after closing.
- The filing is a Regulation FD disclosure under Item 7.01 and does not contain new financial results.
03—Questions
Frequently Asked Questions
What regulatory milestone was reached for the transaction?
The waiting period under the HSR Act expired at 11:59 p.m. ET on February 16, 2024. This expiration was a condition to closing, but other closing conditions remain outstanding.
What conditions still need to be satisfied before the transaction closes?
Completion remains subject to receipt of other regulatory approvals, a private letter ruling from the Internal Revenue Service, opinions from tax advisors, and effectiveness of a registration statement with the U.S. Securities and Exchange Commission.
When does Jacobs expect the transaction to close?
Jacobs expects the transaction to close in the second half of fiscal year 2024.
How much of the combined company's stock will Jacobs keep?
Jacobs does not intend to retain more than 8% of the issued and outstanding shares of the combined company's common stock, after accounting for certain post-closing adjustments to the merger consideration owed to the sole shareholder of Amentum, if any.
What happens to shares Jacobs would otherwise retain above 8%?
Any additional shares above 8% will be distributed to Jacobs' shareholders at the time of, or as soon as reasonably practicable following, the consummation of the transaction.
04—Continue